Logo image of ZYME

ZYMEWORKS INC (ZYME) Stock Analyst Earnings Estimates

NASDAQ:ZYME - Nasdaq - US98985Y1082 - Common Stock - Currency: USD

14.36  +0.06 (+0.42%)

After market: 14.36 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ZYME revenue by date.ZYME revenue by date.
412.5M
1,444.94%
76.012M
-81.57%
76.304M
0.38%
110.42M
44.71%
148.59M
34.57%
134.71M
-9.34%
169.99M
26.19%
230.78M
35.76%
326.5M
41.48%
443.21M
35.75%
433.91M
-2.10%
EBITDA
YoY % growth
ZYME ebitda by date.ZYME ebitda by date.
137.7M
165.85%
-120.748M
-187.69%
-108.63M
10.04%
-118.012M
-8.64%
-107.964M
8.51%
-177.785M
-64.67%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
ZYME ebit by date.ZYME ebit by date.
130.5M
160.53%
-138.053M
-205.79%
-119.823M
13.21%
-121.593M
-1.48%
-141.68M
-16.52%
-172.208M
-21.55%
-125.91M
26.88%
-71.185M
43.46%
18.27M
125.67%
150.72M
724.96%
130.29M
-13.55%
Operating Margin
ZYME operating margin by date.ZYME operating margin by date.
31.64%-181.62%-157.03%-110.12%-95.35%-127.84%-74.07%-30.85%5.60%34.01%30.03%
EPS
YoY % growth
ZYME eps by date.ZYME eps by date.
1.93
146.96%
-1.73
-189.64%
-1.39
19.65%
-1.58
-13.54%
-1.60
-1.53%
-1.71
-6.95%
-1.41
17.86%
-0.71
49.51%
0.07
110.05%
1.65
2,207.14%
1.46
-11.46%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth
-0.42
-8.35%
-0.20
33.95%
-0.15
49.00%
Revenue
Q2Q % growth
31.193M
94.96%
43.611M
40.54%
26.316M
-2.93%
EBITDA
Q2Q % growth
-20.401M
23.59%
11.801M
207.05%
N/A
EBIT
Q2Q % growth
-33.961M
0.71%
-12.349M
44.42%
-40.8M
-59.29%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
0.03
111.11%
-0.500.53105.95%
Q1 2025
Q2Q % growth
-0.30
28.57%
-0.420.1228.01%
Q4 2024
Q2Q % growth
-0.31
-55.00%
-0.10-0.21-206.99%
Q3 2024
Q2Q % growth
-0.39
4.88%
-0.400.013.34%
Q2 2024
Q2Q % growth
-0.27
64.47%
-0.320.0516.42%
Q1 2024
Q2Q % growth
-0.42
-16.67%
-0.30-0.12-41.99%
Q4 2023
Q2Q % growth
-0.20
-104.30%
-0.440.2454.79%
Q3 2023
Q2Q % growth
-0.41
43.06%
-0.480.0714.36%
Q2 2023
Q2Q % growth
-0.76
21.65%
-0.48-0.28-58.39%
Q1 2023
Q2Q % growth
-0.36
65.05%
-0.550.1934.22%
Q4 2022
Q2Q % growth
4.65
711.84%
4.94-0.29-5.81%
Q3 2022
Q2Q % growth
-0.72
38.46%
-0.940.2223.34%
Q2 2022
Q2Q % growth
-0.97
25.95%
-0.980.011.26%
Q1 2022
Q2Q % growth
-1.03
-18.39%
-1.700.6739.39%
Q4 2021
Q2Q % growth
-0.76
-2.70%
-1.160.4034.70%
Q3 2021
Q2Q % growth
-1.17
18.18%
-1.190.021.69%
Q2 2021
Q2Q % growth
-1.31
-70.13%
-1.07-0.24-22.15%
Q1 2021
Q2Q % growth
-0.87
-35.94%
-1.050.1817.46%
Q4 2020
Q2Q % growth
-0.74
55.42%
-1.250.5140.70%
Q3 2020
Q2Q % growth
-1.43
-104.29%
-0.93-0.50-54.53%
Q2 2020
Q2Q % growth
-0.77
10.47%
-0.880.1112.05%
Q1 2020
Q2Q % growth
-0.64
-48.84%
-1.090.4541.27%
Q4 2019
Q2Q % growth
-1.66 -0.88-0.78-88.30%
Q3 2019
Q2Q % growth
-0.70 -0.780.0810.04%
Q2 2019
Q2Q % growth
-0.86 -0.68-0.18-27.04%
Q1 2019
Q2Q % growth
-0.43 -0.550.1221.90%
ZYME Yearly EPS VS EstimatesZYME Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
48.726M
153.21%
19.763M28.963M146.55%
Q1 2025
Q2Q % growth
27.11M
170.29%
21.066M6.044M28.69%
Q4 2024
Q2Q % growth
31.031M
83.33%
46.104M-15.073M-32.69%
Q3 2024
Q2Q % growth
16M
-3.07%
15.609M391K2.50%
Q2 2024
Q2Q % growth
19.243M
174.82%
20.494M-1.251M-6.10%
Q1 2024
Q2Q % growth
10.03M
-71.81%
17.78M-7.75M-43.59%
Q4 2023
Q2Q % growth
16.926M
-95.79%
15.758M1.168M7.41%
Q3 2023
Q2Q % growth
16.506M
534.85%
10.373M6.133M59.12%
Q2 2023
Q2Q % growth
7.002M
29.67%
12.607M-5.605M-44.46%
Q1 2023
Q2Q % growth
35.578M
1,772.53%
19.916M15.662M78.64%
Q4 2022
Q2Q % growth
402.5M
1,922.61%
378.73M23.77M6.28%
Q3 2022
Q2Q % growth
2.6M
-40.91%
4.047M-1.447M-35.75%
Q2 2022
Q2Q % growth
5.4M
200.00%
6.197M-797K-12.86%
Q1 2022
Q2Q % growth
1.9M
216.67%
3.536M-1.636M-46.27%
Q4 2021
Q2Q % growth
19.9M
26.75%
9.315M10.585M113.63%
Q3 2021
Q2Q % growth
4.4M
69.23%
7.487M-3.087M-41.23%
Q2 2021
Q2Q % growth
1.8M
-85.48%
7.24M-5.44M-75.14%
Q1 2021
Q2Q % growth
600K
-92.77%
7.257M-6.657M-91.73%
Q4 2020
Q2Q % growth
15.7M
726.32%
10.506M5.194M49.44%
Q3 2020
Q2Q % growth
2.6M
-67.09%
12.978M-10.378M-79.97%
Q2 2020
Q2Q % growth
12.4M
56.96%
8.28M4.12M49.76%
Q1 2020
Q2Q % growth
8.3M
-30.25%
7.909M391K4.94%
Q4 2019
Q2Q % growth
1.9M 9.667M-7.767M-80.35%
Q3 2019
Q2Q % growth
7.9M 8.678M-778K-8.97%
Q2 2019
Q2Q % growth
7.9M 4.463M3.437M77.01%
Q1 2019
Q2Q % growth
11.9M 4.08M7.82M191.67%
ZYME Yearly Revenue VS EstimatesZYME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -1.47% 0% 7.54%
Revenue0% 7.51% 0% 14.58%